About The Webinar
The past 15 years has seen a number of innovative new treatments for canine atopic dermatitis (CAD) enter the market. However these are not “cure alls” and are no substitute for a systematic approach that targets the underlying disease and secondary complications. The webinar will review:
• The underlying pathogenesis and a description of new treatments
• A brief review of the diagnostic features
• A series of cases with differing features of CAD (but not all of which are suffering from that disease)
For each case treatment options will be discussed focussing on tailoring treatment to the individual case. The webinar will conclude with a discussion of flare factors and the approach to non-responders.